PHARMACOLOGIC AND METABOLIC STUDIES WITH A NEW BETA ADRENERGIC BLOCKING AGENT NADOLOL

dc.contributor.authorWÌLLARD, D JOHNSON
dc.contributor.authorVUKOVICH, RA
dc.contributor.authorHERRERA, JOSE MANUEL DE
dc.contributor.authorDREYFUSS, J
dc.contributor.authorBRANNON, LW
dc.date.accessioned2026-05-28T16:42:51Z
dc.date.issued1976
dc.description.paginacion513 -
dc.description.procedenciaEXT
dc.format.discursoResumen de reunión
dc.format.extent1
dc.identifier.issn0009-9279
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/26836
dc.language.isoInglés
dc.numero.secuencia26833
dc.publisherSQUIBB INST MED RES,PRINCETON,NJ 08540
dc.publisherPRINCETON MED CTR,PRINCETON,NJ
dc.publisherNATL INST NUTR,MEXICO CITY,MEXICO
dc.relation.ispartofseriesVol. 24 No. 3
dc.source.revistafuenteCLINICAL RESEARCH
dc.subjectPHARMACOLOGIC, METABOLIC, STUDIES, NEW BETA ADRENERGIC, BLOCKING AGENT
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaCIENCIAS CLINICAS
dc.subject.subdisciplinaPATOLOGIA CLINICA
dc.titlePHARMACOLOGIC AND METABOLIC STUDIES WITH A NEW BETA ADRENERGIC BLOCKING AGENT NADOLOL
dc.title.alternativeCLIN RES

Files